News From CHEST Physician®
Networks
Challenges in developing effective treatments for idiopathic pulmonary fibrosis: Lessons from the ISABELA trials
Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease that affects an estimated 100,000 people in the United States alone.
Networks
Transitioning from pediatric to adult care
For young adults with chronic health conditions, the process of transitioning to adult health care is complicated, resulting in frustration for...
News From CHEST Physician®
CHEST journal CME program designed to reinforce key points in research
Launched in late 2022, this new initiative was inspired by the desire to complement the excellent clinical work already being done by readers of...
News From CHEST Physician®
CHEST 2023 Master Classes offer advanced learning from big names in chest medicine
Maximize your learning experiences at CHEST 2023 (October 8-11 in Hawai'i) by attending a Master Class.
News From CHEST Physician®
Take this chance to be a mentor at CHEST 2023
One of the most important places that I found mentors was through my involvement with CHEST.
Sleep Strategies
CPAP for OSA: What is the verdict?
Severe OSA has been associated with an elevated risk of all-cause and cardiovascular-specific mortality.
Networks
Lobar vs. sublobar resection in stage 1 lung cancer
Lobectomy with intrathoracic nodal dissection remains the standard of care for early stage NSCLC.
Networks
Beating jet lag at CHEST 2023
Before heading west to the meeting, Dr. Abbott recommends mainland USA travelers get extra light exposure in the evening.
Networks
The STELLAR Travel to BMPR2-based therapies for pulmonary arterial hypertension
Sotatercept improved 6-minute walk distance, the primary endpoint of the trial at 24 weeks,
Networks
RSV: Current patterns and future directions
Respiratory syncytial virus is an underappreciated cause of hospital admission in adult patients.